CareDx (CDNA)
(Real Time Quote from BATS)
$29.85 USD
+1.50 (5.29%)
Updated Aug 16, 2024 01:02 PM ET
2-Buy of 5 2
D Value A Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for CareDx, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 235 | 293 | 348 | 225 | 38 |
Receivables | 51 | 66 | 60 | 35 | 24 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 19 | 19 | 17 | 10 | 6 |
Other Current Assets | 8 | 9 | 8 | 4 | 4 |
Total Current Assets | 314 | 388 | 433 | 273 | 72 |
Net Property & Equipment | 35 | 36 | 22 | 11 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 86 | 81 | 87 | 68 | 69 |
Deposits & Other Assets | 2 | 4 | 6 | 1 | 1 |
Total Assets | 467 | 543 | 567 | 369 | 152 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 10 | 13 | 10 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 65 | 66 | 64 | 39 | 29 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 21 | 0 |
Total Current Liabilities | 78 | 76 | 77 | 69 | 35 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 99 | 3 | 6 | 4 | 16 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 206 | 112 | 101 | 91 | 53 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 947 | 899 | 854 | 632 | 438 |
Retained Earnings | -678 | -460 | -383 | -353 | -334 |
Other Equity | -7 | -8 | -5 | -2 | -5 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 261 | 431 | 466 | 278 | 99 |
Total Liabilities & Shareholder's Equity | 467 | 543 | 567 | 369 | 152 |
Total Common Equity | 261 | 431 | 466 | 278 | 99 |
Shares Outstanding | 54.10 | 53.50 | 52.80 | 49.20 | 42.40 |
Book Value Per Share | 4.83 | 8.05 | 8.82 | 5.64 | 2.33 |
Fiscal Year End for CareDx, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 229 | 216 | 235 | 268 | 283 |
Receivables | 66 | 60 | 51 | 52 | 52 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 19 | 20 | 19 | 18 | 19 |
Other Current Assets | 6 | 7 | 8 | 7 | 8 |
Total Current Assets | 321 | 303 | 314 | 345 | 361 |
Net Property & Equipment | 34 | 34 | 35 | 35 | 36 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 82 | 84 | 86 | 87 | 83 |
Deposits & Other Assets | 3 | 3 | 2 | 3 | 3 |
Total Assets | 467 | 452 | 467 | 501 | 515 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 6 | 10 | 13 | 9 | 10 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 72 | 60 | 65 | 64 | 65 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 78 | 70 | 78 | 73 | 75 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 98 | 99 | 5 | 4 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 202 | 196 | 206 | 107 | 110 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 969 | 960 | 947 | 937 | 924 |
Retained Earnings | -697 | -695 | -678 | -534 | -510 |
Other Equity | -8 | -8 | -7 | -9 | -8 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 265 | 256 | 261 | 394 | 405 |
Total Liabilities & Shareholder's Equity | 467 | 452 | 467 | 501 | 515 |
Total Common Equity | 265 | 256 | 261 | 394 | 405 |
Shares Outstanding | 52.70 | 51.70 | 54.10 | 54.10 | 53.70 |
Book Value Per Share | 5.02 | 4.96 | 4.83 | 7.29 | 7.55 |